Virtus Biotech ETF BBP
94.61 USD -2.20 (-2.27%)
As ofNov 20, 2026, 3:36 PM EST
95.28 Day range 96.37
73.97 52-week range 110.05
- YTD
- +18.38%
- 1 year
- +25.61%
No chart data for this range yet.
- Assets
- $135.69M
- Expense ratio
- 0.34%
- NAV
- 104.38
- Holdings
- 198
- Top 10 weight
- 28.4%
- Asset class
- Sector Equity
- Issuer
- Virtus
- Inception
- Dec 16, 2014
- YTD return
- +18.38%
- 1-year return
- +25.61%
- Volume
- 7.69K
- Avg volume
- 12.60K
- Open
- 96.25
- Previous close
- 96.81
- Day's range
- 95.28 – 96.37
- 52-week range
- 73.97 – 110.05
- 50-day average
- 63.72
- 200-day average
- 60.18
About Virtus Biotech ETF
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on BBP — it syncs with the Stock Master app.
